March 1, 2010 (FinancialWire) — The Hanover Insurance Group, Inc. (NYSE: THG) said that its board of directors has authorized a $100 million increase to the company’s existing share repurchase program. With this authorization, as of February 25, 2010, the company has around $181 million remaining under its aggregate authorization of $400 million.

Separately, The Hanover’s directors declared a dividend of 25 cents per share on the issued and outstanding common stock of the company, payable March 22, 2010, to shareholders of record at the close of business on March 8, 2010. Massachusetts-based Hanover Insurance is the holding company for a group of insurers that includes The Hanover Insurance Co., Citizens Insurance Co. of America, and their affiliates.

FinancialWire(tm) is committed to serving the financial community through true journalism and providing relevant resources to investors. Standards-based, independent equity research on numerous public companies is available through the Investrend Research Syndicate (http://www.investrend.com/reports) written by FIRST Research Consortium (http://www.investrend.com/FIRST) member-providers. Free annual reports and company filings for companies mentioned in the news are available through the Investrend Information Syndicate (at http://investrend.ar.wilink.com/?level=279). FinancialWire(tm), in cooperation with the Investrend Broadcast Syndicate, also provides complete, daily conference call and webcast schedules as a service to shareholders and investors via the FirstAlert(tm) Network’s “FirstAlert(tm) Daily” (http://www.financialwire.net/news-alerts/).

FinancialWire(tm) is a fully independent, proprietary news wire service. FinancialWire(tm) is not a press release service, and receives no compensation for its news, opinions or distributions. Further disclosure is at the FinancialWire(tm) website (http://www.financialwire.net/disclosures.php). Contact FinancialWire(tm) directly via inquiries@financialwire.net.

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.